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resection for elderly high-risk patients with stage
I peripheral non-small-cell lung cancer
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Background: Elderly patients with severe cardiopulmonary and other system dysfunctions are unable to tolerate
pulmonary lobectomy. This study aimed to evaluate the risk and efficacy of wedge resection under video-assisted
thoracoscopic surgery (VATS) on elderly high-risk patients with stage I peripheral non-small-cell lung cancer (PNSCLC).
Methods: Elderly patients (≥70 years) with suspected PNSCLC were divided into high-risk group and conventional risk
group. The high-risk patients confirmed in stage I by the examination of positron emission tomography computed
tomography (PET-CT) and the postoperative patients in stage I PNSCLC with negative incisal margin were treated with
VATS wedge resection. The conventional risk patients were treated with VATS radical resection and systematic
lymphadenectomy. The clinical and pathological data were recorded. The total survival, tumor-free survival, recurrence
time and style of patients were followed up.
Results: The operative time and blood loss of the VATS wedge resection group (69.4 ± 15.5 min, 52.1 ± 11.2 ml) were
significantly less than those of the VATS radical resection group (128 ± 35.5 min, 217.9 ± 87.1 ml). Neither groups had
postoperative death. The overall and tumor-free survival rate of the VATS wedge resection group within three years
were 66.7% and 60.0%, and those of the VATS radical resection group were 93.8% and 94.1%, without significant
difference (P > 0.05). The recurrence rates of the VATS wedge resection group and VATS radical resection group were
14.3% and 3.0%, without significant difference (P > 0.05).
Conclusion: It is safe, minimally invasive and meaningful to perform VATS wedge resection on the elderly high-risk
patients with stage I PNSCLC.
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Lung cancer is a leading cause of cancer-related mortal-
ity and a common disease of the elderly. The statistics of
National Cancer Institute have shown that the lung can-
cer mainly occurs in those aged between 75 and 79 and
the peak mortality rate is between 75 and 84 years, de-
pending on gender [1]. The prognosis of lung cancer is
poor and less than 15% of patients could survive 5 years
after diagnosis. The lack of efficient diagnostic methods
and successful treatment for early detection and meta-
static disease caused the poor prognosis [2].* Correspondence: hudingzhong@hotmail.com
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reproduction in any medium, provided the orApproximately 85% of all lung cancers are classified as
non-small-cell lung cancer (NSCLC), 10% are small cell
lung cancer and 5% other histological variants with dis-
tinct biological behavior, genetic alterations, and therapy
[3,4]. The NSCLC is potentially curable by surgical re-
section if it is discovered at an early stage [5]. And the
locally advanced NSCLC is treated with radiotherapy or
chemotherapy [6]. Pulmonary lobectomy is the removal
of one of the five lobes of the lung and wedge resection
is the removal of the lung tumor and a rim of healthy
lung tissue around the tumor [1,7]. Pulmonary lobectomy
combined with systematic lymphadenectomy or sampling
is the accepted standard treatment for lung cancer cur-
rently. However, the risk of operation is gradually rising
along with the rise of age [8]. Some clinical, socioeconomic,. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ciated with the choice of surgical resection for early-
stage NSCLC [9].
The technique of video-assisted thoracic surgery (VATS)
is a well-established technique in the armamentarium of
the thoracic surgeon and currently indicated for a wide
spectrum of pulmonary diseases, including primary lung
cancer [10,11]. The risk of pulmonary lobectomy for eld-
erly patients is greatly reduced along with the maturity of
thoracoscopic lobectomy and lymphadenectomy , and ad-
vanced age is no longer a barrier of the VATS radical resec-
tion [12]. Nevertheless, a lot of elderly patients usually
have severe cardiopulmonary and other system dysfunc-
tions and are unable to tolerate the pulmonary lobectomy.
It could only be a local excision though these elderly high-
risk patients treated withVATS. And the systematic lymph-
adenectomy or sampling might be simplified or omitted
because of the operative risk. Thus, patients who severely
compromised pulmonary function, advanced age or other
extensive comorbidity cannot tolerate a full lobectomy, a
more limited operation is recommended [13-15].
Therefore, we undertook this study to evaluate the op-
erative risk of VATS wedge resection performed on elderly
high-risk patients with stage I peripheral non-small-cell
lung cancer (PNSCLC) and the therapeutic effects of the
VATS wedge resection for these patients.
Methods
Studying subjects
All of the patients 70 or above 70 years old diagnosed
from May 2008 to June 2012 with suspected PNSCLC
were collected. This study was approved by the Research
Ethics Committee of Shanghai Jiao Tong University School
of Medicine and all participants at the Shanghai Chest
Hospital gave written informed consent.
Physical examination and routine examination of these
patients were performed. Routine check-up included the
examinations of preoperative blood biochemical indexes,
chest radiography, chest CT, electrocardiogram, heart
of color Doppler ultrasound, lung function and arterial
blood gases.
The patients were identified to be high-risk if one of
the following descriptions had conformed to the medical
history and preliminary results. Otherwise, the patients
were subjected into the conventional risk group. The cri-
teria for high-risk were shown as follows:
(1) Pulmonary function test: the percentage ratio of
forced expiratory volume in 1 second (FEV1) to predicted
value < 60% or the absolute value of FEV1 < 1.2 L or the
percentage ratio of carbon monoxide diffusion capacity
(DLCO) to predicted value < 60%. (2) Arterial blood gas
analysis of suction air in a calm case: PaO2 ≤ 60 mmHg or
PaCO2 ≥50 mmHg. (3) Including three items of the fol-
lowing symptoms: Primary hypertension in or above stageII, diabetes for more than 2 years and abnormal levels
of glycated hemoglobin and microalbuminuria with poor
glucose control, undergoing coronary stenting of myo-
cardial infarction or coronary artery within two years, mod-
erate and increased level of valvular disease, frequent
ventricular arrhythmia, the left ventricular ejection frac-
tion < 60%, a history of cerebrovascular accident within two
years, undergoing pulmonary lobectomy and more serious
operations, renal insufficiency and the value of serum cre-
atinine to the normal value ≥ 2, compensated cirrhosis, not-
able marasmus with reduced total protein, albumin and
prealbumin of blood, a history of hemorrhagic disease with
abnormal clotting.
The examinations of positron emission tomography
computed tomography (PET-CT) for patients considered
to be high-risk were performed. The patients with stage
I PNSCLC received the treatment of VATS lung wedge
resection when the results of PET-CT had indicated that
the lung vicinity tubercle was likely to be malignant. The
case would be counted into the elderly high-risk group
with the treatment of VAST wedge resection if the patient
was confirmed to be in stage I by postoperative pathology
and had a negative surgical margin.
The preoperative patients with stage I PNSCLC of con-
ventional risk group were received the VAST radical resec-
tion and the systematic lymphadenectomy. The case would
be counted into the elderly conventional risk group with
the treatment of VAST radical resection if the patient was
confirmed to be in the stage I by postoperative pathology.
By the end of June 2012, the cases of the elderly high-
risk group with the treatment of VAST wedge resection
and the elderly conventional risk group with the treatment
of VAST radical resection were 14 and 33, respectively.Operative procedure
The VAST radical resection group: The patients were re-
quired with conventional lateral position. A 1.5 cm inci-
sion was made in the 8th rib under scapula as the exits
and entrances of cut staplers and sponge clamp. A 4-5 cm
incision was made at inner side of the anterior axillary line
between the 4th and 5th rib acting as the operation re-
cesses and the outlet of samples according to the resected
pulmonary lobe. Bronchia, pulmonary vasculature and
inter-lobar fissure were cut off or sutured by the corre-
sponding endoscopic cut stapler respectively. Then system-
atic lymphadenectomy was performed. The VAST wedge
resection group: The operative incision was the same as the
previous group or the incision in the 8th rib under scapula
was omitted, and the patients were required with conven-
tional lateral position. Wedge-shaped excision of lung was
performed 2 cm from the edge of the tumor using endo-
scopic cut stapler after the location of the tumor was deter-
minated by palpation and video.
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prepared immediately. The lymphadenectomy or sampling
wasn’t performed on the patients of the wedge resection
group.
Data collecting
The age, gender, site of the tumor, operative time, blood
loss, postoperative complications, hospital stay, postopera-
tive deaths within 30 days, size of the tumor, pleural inva-
sion, T stage and pathological stage of the 47 cases were
collected. And the histological type and differentiation of
tumor were determinated by histological sections. Postop-
erative complications were the symptoms that occurred
within 30 days post operation including myocardial infarc-
tion, arrhythmia, pulmonary infarction, lower limb venous
embolism, postoperative leakage above 7 days, rebleeding,
bronchopleural fistula, chest or lung infection, wound in-
fection, chylothorax and respiratory failure.
The overall survival, tumor-free survival, time and pat-
terns of recurrence of all patients were collected by follow-
up visits. It was necessary to provide pathological evidence
of the recurrence and metastasis of tumor as much as pos-
sible in principle, such as, lymph node biopsies or needle
biopsy of lung. It could be inferred as recurrence or metas-
tasis when more than two different imaging examinations
had demonstrated the possibility of metastasis in the con-
dition that unable to obtain pathology.
Statistical analysis
Statistical analysis was performed by the SPSS version 12.0
statistical software. The measurement data were expressed
as X  SD and analyzed by T-test. Meanwhile, χ2-test was
used to analyze the enumeration data. The method of
Kaplan-Meier was applied to analyze the overall survival
and the tumor-free survival, and the statistical evaluation
was conducted by Log-Rank test. There is significantly
statistical difference when P <0.05.
Results
Comparison of the clinical and pathological data
The clinical and pathological data were shown in Table 1.
There was no significant difference in the age, gender,
position of the tumor, tumor size, histological type, dif-
ferentiation, pleural invasion, T stage and pathological
stage between the two groups. The histological types of
VATS wedge resection group were 2 cases of bronchiolo-
alveolar carcinoma, 9 cases of adenomatous carcinoma, 2
cases of squamous carcinoma and 1 case of adenosqua-
mous carcinoma. The histological types of VATS radical
resection group were 1 case of bronchioloalveolar carcin-
oma, 23 cases of adenomatous carcinoma, 5 cases of squa-
mous carcinoma, 1 case of adenosquamous carcinoma
and 3 cases of large cell carcinoma. Though the clinicaland pathological data of the two groups had no obvious
difference, the proportions of bronchioloalveolar carcin-
oma and high differentiated tumor in the VATS wedge re-
section group were slightly increased.
Comparison of the postoperative recovery and
follow-up visits
The postoperative recovery and follow-up visits of the
two groups were shown in Table 2. There was no signifi-
cant difference in hospital stay, average follow-up time
and postoperative complications between the two groups.
Both of the two groups had no postoperative death within
30 days. The operative time of VATS wedge resection
group was 69.4 ± 15.5 min, and was significantly reduced
compared with the 128 ± 35.5 min of VATS radical resec-
tion group (P < 0.05). The blood loss of VATS wedge re-
section group was 52.1 ± 11.2 ml, and was significantly
reduced compared with the 217.9 ± 87.1 ml of VATS rad-
ical resection group (P < 0.05).
The three cases of the complications of the VATS
wedge resection group were atrial fibrillation, pneumonia
and air leakage above 7 days. The four cases of the VATS
radical resection group were two cases of atrial fibrillation,
one case of pneumonia and one case of air leakage above
7 days.
The recurrence rates of the VATS wedge resection
group and VATS radical resection group were 14.3% and
3.0%, without significant difference (P > 0.05). The two
cases of the postoperative recurrence of the VATS wedge
resection group were local recurrence and distant metas-
tasis according to the follow-up visit. The case of local re-
currence was a 79-year-old patient whose histological type
was bronchioloalveolar carcinoma. The recurrence of the
resection occurred at 26 months after the operation and
the patient died of severe lung infections at 32 months
postoperatively. The case of distant metastasis was a 78-
year-old patient whose histological type was moderately
differentiated adenocarcinoma. The brain metastase was
appeared at 22 months postoperatively and the bone me-
tastases occurred after the γ-knife treatment, and the pa-
tient died of lung cancer at 42 months after the operation.
There was only one distant metastasis of the VATS radical
resection group according to the follow-up visit. It was
a 74-year-old patient with large cell carcinoma. A wide
range of bone metastases and brain metastases were ap-
peared at 28 months postoperatively and the patient died
of lung cancer at 21 months postoperatively. There was
not any death caused by anything other than lung cancer
during this study period.
As shown in Figure 1 and Figure 2, the statistical re-
sults of survival indicated that the overall survival rate
and tumor-free survival rate of the VATS wedge resection
group within three years were 66.7% and 60.0%. And the
overall survival rate and tumor-free survival rate of the
Table 1 Comparison of the clinical and pathological data
VATS wedge resection (n = 14) VATS radical resection (n = 33) P value
Age (years) 74.93 ± 3.12 72.82 ± 2.92 0.943
Gender Male 9 20 0.812
Female 5 13
Site of the tumor Right upper lobe 5 (35.7%) 9 (27.3%) 0.721
Right middle lobe 1 (7.1%) 4 (12.1%)
Right lower lobe 1 (7.1%) 7 (21.2%)
Left upper lobe 5 (35.7%) 8 (24.2%)
Left lower lobe 2 (14.3%) 5 (15.2%)
Histological type Bronchioloalveolar carcinoma 2 (14.3%) 1 (3.0%) 0.527
Adenomatous carcinoma 9 (64.3%) 23 (69.7%)
Squamous carcinoma 2 (14.3%) 5 (15.2%)
Others 1 (7.1%) 4 (12.1%)
Tumor size (cm) 2.24 ± 0.56 2.33 ± 0.82 0.094
Differentiation Low 1 (7.1%) 8 (24.2%) 0.134
Medium 9 (64.3%) 22 (66.7%)
High 4 (28.6%) 3 (9.1%)
Pleural invasion With 4 (28.6%) 8 (24.2%) 0.756
Without 10 (71.4%) 25 (75.8%)
T-stage 1a 6 (42.9%) 12 (36.4%) 0.865
1b 4 (28.6%) 9 (27.3%)
2a 4 (28.6%) 12 (36.4%)
Pathological stage IA 10 (71.4%) 21 (63.6%) 0.606
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93.8% and 94.1%. There was no statistically significant dif-
ference in the overall survival rate and tumor-free survival
rate between the two groups. And the P values of the two
groups were 0.213 and 0.081, respectively.Table 2 Comparison of the postoperative recovery and
follow-up visits
VATS wedge
resection (n = 14)
VATS radical
resection (n = 33)
P value
Operative time (min) 69.4 ± 15.5 128 ± 35.5 0.020
Blood loss (ml) 52.1 ± 11.2 217.9 ± 87.1 0.025
Postoperative
complications
3 (21.4%) 4 (12.2%) 0.412






17.93 ± 16.14 20.85 ± 11.71 0.094
Postoperative
recurrence
2 (14.3%) 1 (3.0%) 0.149
Local recurrence 1 (7.1%) 0 (0%) 0.121
Distant metastasis 1 (7.1%) 1 (3.0%) 0.523Discussion
Along with the aging of the society and the universalness
of the physical examination, there are more and more
elderly patients with stage I lung cancer. In this study,
there were 8 elderly high-risk cases from May 2008 to
December 2011 while the number of elderly high-risk
cases was 6 in the first half of 2012. Therefore, the num-
ber of elderly high-risk cases is increasing and this situ-
ation is becoming a trend.
There is significant relationship between the rate of
postoperative complications and the rate of preoperative
complications [16]. So, our determination to perform the
VATS radical resection is usually disturbed by the preopera-
tive complications of patients. How to choose a proper
operation method according to the specific situation of
the elderly patients has not been determined. Mean-
while, the balance between survival and risk of the oper-
ation is the key to whole choice.
The safety of the VATS wedge resection performed on
elderly high-risk patients was the primary issue to be
considered in this study, and a standard for the risk as-
sessment was established according to the related litera-
tures and our previous experience in operation [17-19].
It has been reported that wedge resections could obtain
Figure 1 The overall survival of VATS radical resection group
and VATS wedge resection group.
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mies and segmentectomies in stage IA NSCLC patients
[20]. However, the prognostic impact of wedge resec-
tions and segmentectomies is still under debate. Wedge
resections with lymph node sampling can be more easily
performed using VATS techniques than segmentectomy.
In this study, the elderly patients with stage I PNSCLC
were divided into two groups: the high-risk group andFigure 2 The tumor-free survival of VATS radical resection
group and VATS wedge resection group.conventional risk group. The VATS wedge resection was
conducted on the patients of high-risk group because
the risk of VATS radical resection for high-risk group
was extremely high. Meanwhile, the group of conven-
tional risk received the treatment of VATS radical resec-
tion. Both of the two groups had no postoperative death,
and the incidence of complications was 12.2% in the
conventional risk group. It has been reported that the
incidence of complications in patients over 80 years old
received the treatment of VATS radical resection is 18-
35% [21-23]. The incidence of complications of conven-
tional risk group was lower than the reports presented,
which may be related to the age of the conventional risk
group in our study. There was only one case of patient
above 80 years and the ages of the conventional risk
group were mainly between 70-79 years. The incidence
of complications of high-risk group was 21.4% and had
no obvious difference compared with the conventional
risk group. The operative time and blood loss of high-
risk group were lower than the conventional risk group
since the VATS wedge resection was conducted on the
patients of high-risk group. Therefore, this difference
was caused by the options of operation. Long operative
time and more bleeding are the dangerous factors that
lead to the high incidence of complications and mortal-
ity [16,24]. Thus, it is feasible and safe to perform VATS
wedge resection on the elderly high-risk patients.
Another critical factor that affected our decision was
survival since the operative risk of performing VATS
wedge resection on the elderly high-risk patients was ac-
ceptable. Vrdoljal et al reported that the average survival
time was 17 months and the survival rate was 20% within
two years while patients with stage I lung cancer had no
treatment [25]. Morita et al analyzed the therapeutic ef-
fects of 149 patients with stage I PNSCLC that received
the radical radiotherapy. The analysis results showed that
the average survival time was 27.2 months and the sur-
vival rates were 34.2% and 22.2% within 3 and 5 years
respectively [26]. The related foreign literatures have re-
ported that the survival rates were 76-84.2% and 55.6-
75% within 3 and 5 years after the patients above 80 years
with stage I lung cancer received the treatment of VATS
radical resection [16,22,23,27]. In this study, the total sur-
vival rate and tumor-free survival rate of the elderly high-
risk group treated with the VATS wedge resection within
3 years were 66.7% and 60.0%, and those of the conven-
tional risk group treated with the VATS radical resection
and systematic lymphadenectomy within 3 years were
93.8% and 94.1%. Thus, the total survival rate of conven-
tional risk group was higher than the reports presented
above. The reason was that the patients of the con-
ventional risk group were 10 years younger and had no
obvious contraindications and fewer complications. The
patients of the elderly high-risk group in this study were
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in the past. The survival rate of the elderly high-risk group
within 3 years after the VATS wedge resection was signifi-
cantly higher than the reported patients with no treatment
or treated with radical radiotherapy. The research about
randomized controlled trial of the early lung cancer by
Lung Cancer Study Group (LCSG) in 1995 showed that
there was no significant difference in survival rate within
3 years between the pulmonary lobectomy and local resec-
tion [28]. Large sample retrospective analysis by Mery et al
in 2005 showed the effect of local resection on the total
survival rate depending on age and there was no signifi-
cant difference in survival rate between the local resection
and pulmonary lobectomy for the patients above 71 years
[1]. The research result announced in Japanese multicenter
by Okada et al in 2006 showed that there was no signifi-
cant difference in recurrence rate between local resection
and pulmonary lobectomy [20]. In this study, there was no
significant difference in survival rate, local recurrence, dis-
tant metastasis and total recurrence rate between the two
groups. Thus, these results were similar with the conclu-
sion of randomized study and large sample retrospective
analysis aboard.
Based on the above research results, it is reasonable to
believe that the prognosis of elderly high-risk patients with
stage I lung cancer that are treated with VATS wedge re-
section will be much better than the patients that receive
no treatment. What’s more, the medium-term survival rate
and relapse metastasis rate of the VATS wedge resection
will not be worse than the VATS radical resection and the
survival benefit of the VATS wedge resection is very obvi-
ous. However, there are some weaknesses and limitations
in our study, such as the small sample size and short-term
follow-up. Therefore, further researches with larger sample
size and longer follow-up are needed to evaluate the safety
and efficacy of thoracoscopic wedge resection for elderly
high-risk patients with stage I peripheral non-small-cell
lung cancer.Conclusions
In conclusion, it appears to be safe and meaningful for
tumorous therapy when the elderly high-risk patients with
stage I PNSCLC were treated with VATS wedge resection,
and the VATS wedge resection could avoid the problem
that patients died of lung cancer in early stage. What’s
more, the comparison of long-term effect still needs follow-
up visits for longer time and more patients in consideration
of the limitation of clinical time.Abbreviations
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